Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding

Sex Transm Dis. 2011 Sep;38(9):865-70. doi: 10.1097/OLQ.0b013e31821d4ceb.

Abstract

Background: Episodic acyclovir therapy has been added to genital ulcer disease (GUD) syndromic management guidelines in several sub-Saharan African countries with human immunodeficiency virus (HIV) epidemics. We examined the correlates of health care seeking in men with GUD and its relationship to HIV-1 and herpes simplex virus type 2 outcomes.

Methods: Men with GUD (n = 615) were recruited from primary health care clinics in Gauteng province, South Africa for a randomized controlled trial of episodic acyclovir therapy. We used baseline survey and sexually transmitted infection/HIV-testing data to examine delay in health care seeking (defined as time from ulcer recognition to baseline study visit).

Results: Median delay in health care seeking for GUD was 5 days, and one-quarter of men had previously sought care for the current ulcer. Previous care seekers were older, had more episodes of ulceration in the past year, and were more likely to test seropositive for HIV-1 and HSV-2. Delay in health care seeking was significantly associated with age, education level, and sex during the ulceration episode. Delays in care seeking were related to poorer HIV-1 outcomes; these findings were valid after controlling for advanced HIV.

Conclusions: Interventions to help shorten the duration between ulcer recognition and health care seeking for men with GUD are needed.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acyclovir / therapeutic use
  • Adolescent
  • Adult
  • Age Factors
  • Antiviral Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Delayed Diagnosis
  • Genital Diseases, Male / complications
  • Genital Diseases, Male / drug therapy
  • Genital Diseases, Male / epidemiology
  • Genital Diseases, Male / virology
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV Infections / virology
  • HIV-1 / isolation & purification*
  • HIV-1 / physiology
  • Herpes Genitalis / complications
  • Herpes Genitalis / drug therapy
  • Herpes Genitalis / epidemiology*
  • Herpes Genitalis / virology
  • Herpesvirus 2, Human / isolation & purification*
  • Herpesvirus 2, Human / physiology
  • Humans
  • Male
  • Middle Aged
  • Patient Acceptance of Health Care / statistics & numerical data*
  • Sex Factors
  • Sexual Behavior
  • Sexually Transmitted Diseases / complications
  • Sexually Transmitted Diseases / drug therapy
  • Sexually Transmitted Diseases / epidemiology
  • Sexually Transmitted Diseases / virology
  • South Africa / epidemiology
  • Treatment Outcome
  • Ulcer / complications
  • Ulcer / drug therapy
  • Ulcer / epidemiology*
  • Ulcer / virology
  • Viral Load
  • Virus Shedding / physiology
  • Young Adult

Substances

  • Antiviral Agents
  • Acyclovir